These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 38625857)

  • 1. Biophysical characterization of the CXC chemokine receptor 2 ligands.
    Martin P; Kurth EA; Budean D; Momplaisir N; Qu E; Simien JM; Orellana GE; Brautigam CA; Smrcka AV; Haglund E
    PLoS One; 2024; 19(4):e0298418. PubMed ID: 38625857
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic assessment of chemokine ligand bias at the human chemokine receptor CXCR2 indicates G protein bias over β-arrestin recruitment and receptor internalization.
    Boon K; Vanalken N; Szpakowska M; Chevigné A; Schols D; Van Loy T
    Cell Commun Signal; 2024 Jan; 22(1):43. PubMed ID: 38233929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface heparan sulfate participates in CXCL1-induced signaling.
    Wang D; Sai J; Richmond A
    Biochemistry; 2003 Feb; 42(4):1071-7. PubMed ID: 12549928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the molecular interactions of interleukin-8 (CXCL8), growth related oncogen alpha (CXCL1) and a non-peptide antagonist (SB 225002) with the human CXCR2.
    Catusse J; Liotard A; Loillier B; Pruneau D; Paquet JL
    Biochem Pharmacol; 2003 Mar; 65(5):813-21. PubMed ID: 12628493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CXC chemokine receptor-2 ligands are necessary components of neutrophil-mediated host defense in invasive pulmonary aspergillosis.
    Mehrad B; Strieter RM; Moore TA; Tsai WC; Lira SA; Standiford TJ
    J Immunol; 1999 Dec; 163(11):6086-94. PubMed ID: 10570298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential usage of the CXC chemokine receptors 1 and 2 by interleukin-8, granulocyte chemotactic protein-2 and epithelial-cell-derived neutrophil attractant-78.
    Wuyts A; Proost P; Lenaerts JP; Ben-Baruch A; Van Damme J; Wang JM
    Eur J Biochem; 1998 Jul; 255(1):67-73. PubMed ID: 9692902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum amyloid A1α induces paracrine IL-8/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils.
    De Buck M; Berghmans N; Pörtner N; Vanbrabant L; Cockx M; Struyf S; Opdenakker G; Proost P; Van Damme J; Gouwy M
    J Leukoc Biol; 2015 Dec; 98(6):1049-60. PubMed ID: 26297794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discrete steps in binding and signaling of interleukin-8 with its receptor.
    Wu L; Ruffing N; Shi X; Newman W; Soler D; Mackay CR; Qin S
    J Biol Chem; 1996 Dec; 271(49):31202-9. PubMed ID: 8940121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotinamide N-oxides as CXCR2 antagonists.
    Cutshall NS; Ursino R; Kucera KA; Latham J; Ihle NC
    Bioorg Med Chem Lett; 2001 Jul; 11(14):1951-4. PubMed ID: 11459668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of G protein-coupling in CXCR2 does not alter ligand binding, but eliminates ligand-activation of GTPgamma35S binding, calcium mobilization, and chemotaxis.
    Yang W; Schraw WP; Mueller SG; Richmond A
    Biochemistry; 1997 Dec; 36(49):15193-200. PubMed ID: 9398246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial clearance and survival are dependent on CXC chemokine receptor-2 ligands in a murine model of pulmonary Nocardia asteroides infection.
    Moore TA; Newstead MW; Strieter RM; Mehrad B; Beaman BL; Standiford TJ
    J Immunol; 2000 Jan; 164(2):908-15. PubMed ID: 10623839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and function of the chemokine receptors CXCR1 and CXCR2 in sepsis.
    Cummings CJ; Martin TR; Frevert CW; Quan JM; Wong VA; Mongovin SM; Hagen TR; Steinberg KP; Goodman RB
    J Immunol; 1999 Feb; 162(4):2341-6. PubMed ID: 9973513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
    Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
    J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity.
    Addison CL; Daniel TO; Burdick MD; Liu H; Ehlert JE; Xue YY; Buechi L; Walz A; Richmond A; Strieter RM
    J Immunol; 2000 Nov; 165(9):5269-77. PubMed ID: 11046061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of AZD5069, a slowly reversible CXC chemokine receptor 2 antagonist.
    Nicholls DJ; Wiley K; Dainty I; MacIntosh F; Phillips C; Gaw A; Mårdh CK
    J Pharmacol Exp Ther; 2015 May; 353(2):340-50. PubMed ID: 25736418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Clinicopathological Significance of the CXCR2 Ligands, CXCL1, CXCL2, CXCL3, CXCL5, CXCL6, CXCL7, and CXCL8 in Gastric Cancer.
    Yamamoto Y; Kuroda K; Sera T; Sugimoto A; Kushiyama S; Nishimura S; Togano S; Okuno T; Yoshii M; Tamura T; Toyokawa T; Tanaka H; Muguruma K; Ohira M; Yashiro M
    Anticancer Res; 2019 Dec; 39(12):6645-6652. PubMed ID: 31810929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2.
    Ludwig A; Petersen F; Zahn S; Götze O; Schröder JM; Flad HD; Brandt E
    Blood; 1997 Dec; 90(11):4588-97. PubMed ID: 9373270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin 8, neutrophil-activating peptide-2 and GRO-alpha bind to and elicit cell activation via specific and different amino acid residues of CXCR2.
    Katancik JA; Sharma A; de Nardin E
    Cytokine; 2000 Oct; 12(10):1480-8. PubMed ID: 11023662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine CXCL1 dimer is a potent agonist for the CXCR2 receptor.
    Ravindran A; Sawant KV; Sarmiento J; Navarro J; Rajarathnam K
    J Biol Chem; 2013 Apr; 288(17):12244-52. PubMed ID: 23479735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.
    Van den Steen PE; Proost P; Wuyts A; Van Damme J; Opdenakker G
    Blood; 2000 Oct; 96(8):2673-81. PubMed ID: 11023497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.